KAPPA-HEALTH
Key Performance Factor Assessment and Valorisation for Successful EU-FP Project Participation of innovative SMEs in the Area of HEALTH
| Coordinatore | EURO TOP SCRL
Organization address
address: AVENUE LOUISE 486-490 contact info |
| Nazionalità Coordinatore | Belgium [BE] |
| Totale costo | 819˙292 € |
| EC contributo | 749˙951 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2007-A |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-07-01 - 2011-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
EURO TOP SCRL
Organization address
address: AVENUE LOUISE 486-490 contact info |
BE (BRUXELLES) | coordinator | 0.00 |
| 2 |
ALMA CONSULTING GROUP SAS
Organization address
address: Domaine des Bois d'Houlbec contact info |
FR (HOULBEC COCHEREL) | participant | 0.00 |
| 3 |
BEACON TECH LTD
Organization address
address: OPPENHEIMER STREET 5 contact info |
IL (REHOVOT) | participant | 0.00 |
| 4 |
EURELATIONS AG
Organization address
address: Technoparkstr 1 contact info |
CH (ZUERICH) | participant | 0.00 |
| 5 |
Maria Tsampoula kai SIA EE
Organization address
address: STAMATAS AND SOLOMOU AVENUE 5A contact info |
EL (STAMATA) | participant | 0.00 |
| 6 |
Steinbeis Innovation gGmbH
Organization address
address: WILLI BLEICHER STRASSE 19 contact info |
DE (STUTTGART) | participant | 0.00 |
| 7 |
VENTURE VALUATION VV AG
Organization address
address: KASERNENSTRASSE 11 contact info |
CH (ZUERICH) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The KAPPA-Health study aims to identify the principle performance factors that account for a successful SME participation in FP6 “Life sciences, genomics and biotechnology for health” and FP7 “Health” theme. The success in terms of quantity such as out-licensing/new products on the market but also the longer term quality in respect of the sustainable survival of the companies and the establishment of winning business partnership will be assessed and valorised. Thus SMEs active in EU FP6/7 joint collaboration are more visible, get access to huge networks and more information a special focus will be on the correlation between FP6/7 collaborations and attracting complementary funding investments e.g. financial services, venture capital and/or additional governmental funds. Identifying the key performance factors and analysing them in collaboration with existing support structures will accelerate and enhance the dissemination and exploitation of the project outcome generated by high-technology and research intensive SMEs in FP6/7. This study will lead to develop a methodology of assessment and valorisation of project outcomes for SMEs. It will facilitate the evaluation of projects with more chance for success and help policy makers to define objectives and intermediate performance targets in FP7 for creating a favourable support environment in Europe with regard to the “Life science and biotechnology – a strategy for Europe” and the Lisbon goals.'
Introduzione (Teaser)
EU funds are available to boost innovation and drive research and technological development. For them to be fully exploited, however, policymakers need to have a better picture of what factors contribute to success.
Descrizione progetto (Article)
For small and medium-sized enterprises (SMEs) to take full advantage of the funds and resources available to them, it is necessary to know more about key performance factors (KPFs). This will also help set a basis for recognising which projects are more likely to succeed as well as for setting objectives and intermediate performance targets. Also, by identifying and analysing KPFs, high-tech and research-intensive project outcomes can be expedited and dissemination of their results optimised.
The 'Key performance factor assessment and valorisation for successful EU-FP project participation of innovative SMEs in the area of Health' (Kappa-health) project is working to identify the key performance factors contributing to successful participation of SMEs in certain Sixth and Seventh Framework Programmes (FP6 and FP7 respectively). The focus is on assessing projects and determining how their outcomes can be exploited to meet user needs (valorisation) in terms of market success, sustainable business and effective partnering.
Special attention is being given to the connection between FP6 and FP7 collaborative projects and the ability of partner SMEs to attract additional funding thanks to heightened visibility and access to large networks and information. In work performed during the first 18 months of this EU-funded project, Kappa-health members set out to identify 10 KPFs that will eventually form a preferred 'check-list' for SMEs. This list can be used to highlight what to take into consideration for better results in life sciences and health-related research projects.
Project partners will work with 40 SMEs to achieve Kappa-health goals. Taking it a step further, select SMEs stand to profit directly from training, support and motivational coaching.